{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T20:00:28Z","timestamp":1759694428583,"version":"3.33.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/01.ta.0000246956.72328.6c","type":"journal-article","created":{"date-parts":[[2007,7,10]],"date-time":"2007-07-10T08:03:37Z","timestamp":1184054617000},"page":"E1-E4","source":"Crossref","is-referenced-by-count":1,"title":["Near Fatal Hemorrhage in Traumatic Bilateral Leg Amputation With Coagulopathy, Acidosis, and Hypothermia and Salvage Therapy With Recombinant Factor VIIa"],"prefix":"10.1097","volume":"63","author":[{"given":"Wolfgang C.","family":"Korte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Moor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-36-20210211","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0002-9610(01)00809-1","article-title":"Reliable variables in the exsanguinated patient which indicate damage control and predict outcome.","volume":"182","author":"Asensio","year":"2001","journal-title":"Am J Surg"},{"key":"R3-36-20210211","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0039-6109(05)70582-X","article-title":"The damage control sequence and underlying logic.","volume":"77","author":"Rotondo","year":"1997","journal-title":"Surg Clin North Am"},{"key":"R5-36-20210211","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.TA.0000066184.20808.A5","article-title":"The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients.","volume":"55","author":"Meng","year":"2003","journal-title":"J Trauma"},{"key":"R6-36-20210211","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005131-199702000-00011","article-title":"Train injuries in children.","volume":"11","author":"Blazar","year":"1997","journal-title":"J Orthop Trauma"},{"key":"R7-36-20210211","first-page":"315","article-title":"Train accidents involving pedestrians, motor vehicles, and motorcycles.","volume":"27","author":"Goldberg","year":"1998","journal-title":"Am J Orthop"},{"key":"R8-36-20210211","first-page":"111","article-title":"Disseminated intravascular coagulation. Clinical and pathophysiological mechanisms and manifestations.","volume":"29","author":"Bick","year":"1999","journal-title":"Haemostasis"},{"key":"R9-36-20210211","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"R10-36-20210211","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000064699","article-title":"Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome.","volume":"108","author":"Zupancic Salek","year":"2002","journal-title":"Acta Haematol"},{"key":"R11-36-20210211","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0003-4975(02)03700-1","article-title":"Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta.","volume":"74","author":"Kastrup","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"R12-36-20210211","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3171\/jns.2002.96.5.0946","article-title":"Application of recombinant activated factor VII during surgery for a giant skull base hemangiopericytoma to achieve safe hemostasis. Case report.","volume":"96","author":"Gerlach","year":"2002","journal-title":"J Neurosurg"},{"key":"R13-36-20210211","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2141.2001.02878.x","article-title":"Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII.","volume":"114","author":"Moscardo","year":"2001","journal-title":"Br J Haematol"},{"key":"R14-36-20210211","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1213\/00000539-200108000-00009","article-title":"An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII.","volume":"93","author":"Hendriks","year":"2001","journal-title":"Anesth Analg"},{"key":"R15-36-20210211","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00001721-200011020-00006","article-title":"Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency.","volume":"11","author":"White","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R16-36-20210211","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9343(99)00398-8","article-title":"Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII.","volume":"108","author":"Vlot","year":"2000","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"R17-36-20210211","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000057301","article-title":"The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients.","volume":"32","author":"Aldouri","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"R18-36-20210211","first-page":"S15","article-title":"Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.","volume":"49","author":"Martinowitz","year":"2002","journal-title":"Can J Anaesth"},{"key":"R19-36-20210211","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00005373-200104000-00021","article-title":"Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.","volume":"50","author":"Martinowitz","year":"2001","journal-title":"J Trauma"},{"key":"R20-36-20210211","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archsurg.133.9.947","article-title":"Is there a limit to massive blood transfusion after severe trauma?","volume":"133","author":"Velmahos","year":"1998","journal-title":"Arch Surg"},{"key":"R21-36-20210211","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2000-8454","article-title":"The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders.","volume":"26","author":"van't Veer","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"R22-36-20210211","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2000-8455","article-title":"The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia.","volume":"26","author":"Monroe","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"R23-36-20210211","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1537-2995.2003.00427.x","article-title":"Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders.","volume":"43","author":"Galan","year":"2003","journal-title":"Transfusion"},{"key":"R24-36-20210211","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-2893.2003.00429.x","article-title":"Modulation of endothelial cell inflammatory integrins and stress markers with rh-factor VIIa in patients with advanced chronic hepatitis C.","volume":"10","author":"Van Thiel","year":"2003","journal-title":"J Viral Hepat"},{"key":"R25-36-20210211","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1055\/s-0037-1613338","article-title":"Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma.","volume":"88","author":"Gando","year":"2002","journal-title":"Thromb Haemost"},{"key":"R26-36-20210211","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2002-09-2761","article-title":"Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation.","volume":"101","author":"Lisman","year":"2003","journal-title":"Blood"}],"container-title":["Journal of Trauma: Injury, Infection &amp; Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ta.0000246956.72328.6c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T03:49:14Z","timestamp":1737258554000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005373-200707000-00036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ta.0000246956.72328.6c","relation":{},"ISSN":["0022-5282"],"issn-type":[{"type":"print","value":"0022-5282"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}